The Patent Finder

Foresee Pharmaceuticals Co., Ltd.

18 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

4
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Matrix Metalloproteinase (MMP) Inhibitors and Methods of Use Thereof (US 11,673,884) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 2 fees due Feb 8 to 28, 2027 · next Feb 8
  • 1 fee due Jul 14, 2027
    The maintenance fee for Pharmaceutical composition and methods of uses (US 10,532,102) comes due Jul 14, 2027. Unpaid by Jan 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,744,207Pharmaceutical compositions with enhanced stability
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,251,956Methods of making pharmaceutical compositions with enhanced stability
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,646,572Pharmaceutical compositions with enhanced stability
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,572,857Pharmaceutical compositions with enhanced stability
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,532,102Pharmaceutical composition and methods of uses
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,013,810Pharmaceutical composition and methods of uses
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,628,220Pharmaceutical Composition and Methods of Uses
In force
 · Low confidence
In forceLow confidence
US 12,133,878Pharmaceutical Compositions having a Selected Release Duration
In force
 · High confidence
In forceHigh confidence
US 11,717,555Pharmaceutical Compositions having a Selected Release Duration
In force
 · High confidence
In forceHigh confidence
US 11,419,866Pharmaceutical composition for sustained release delivery of buprenorphine
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
Also on record, not counted in the 18: 5 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 2 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited